Literature DB >> 457421

Immunologic diagnosis of alpha-thalassemia traits.

P Wasi, P Pravatmuang, P Winichagoon.   

Abstract

Frequently it is impossible to diagnose alpha-thalassemia-2 trait from hematologic findings, since the red cell morphology and the MCV are normal. In such cases, after the neonatal period Hb Bart's is not detectable by conventional electrophoreses and chromatography. Antibody against Hb Bart's was produced in rabbits by repeated injections with Hb Bart's from Hb Bart's hydropic fetuses. The antibody was specific for Hb Bart's without crossreaction with Hbs A, A2, E, F and H. By the capillary tube precipitin test Hb Bart's was demonstrable in 82% of 87 obligatory cases for alpha-thalassemia traits, 86% in alpha-thalassemia-1 trait and 79% in alpha-thalassemia-2 trait. The test was positive in 21% of the general subjects, corresponding to the prevalence of alpha-thalassemia in Bangkok. Thus the immunologic demonstration of Hb Bart's appears to offer a diagnostic screening test for alpha-thalassemia traits in the postneonatal period.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457421     DOI: 10.3109/03630267909069152

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  2 in total

1.  Simple method for screening of alpha-thalassaemia 1 carriers.

Authors:  Chatchai Tayapiwatana; Surakit Kuntaruk; Thanusak Tatu; Sawitree Chiampanichayakul; Thongperm Munkongdee; Pranee Winichagoon; Suthat Fuchareon; Watchara Kasinrerk
Journal:  Int J Hematol       Date:  2009-05-14       Impact factor: 2.490

2.  Impact of the detection of ζ-globin chains and hemoglobin Bart's using immunochromatographic strip tests for α0-thalassemia (--SEA) differential diagnosis.

Authors:  Supansa Pata; Witida Laopajon; Matawee Pongpaiboon; Weeraya Thongkum; Nattapong Polpong; Thongperm Munkongdee; Kittiphong Paiboonsukwong; Suthat Fucharoen; Chatchai Tayapiwatana; Watchara Kasinrerk
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.